合成路线1
该中间体在本合成路线中的序号:
(V) The synthesis of [14C]-mitoguazone has been reported:
The methylation of [14C]-labeled potassium acetate (I) with dimethyl sulfate in HMPT gives the corresponding ester (II), which by reaction with the sodium salt of dimethylsulfoxide (III) in DMSO affords the hemithioketal (IV). Finally, this compound is condensed with aminoguanidine (V) in DMSO/water.
【1】
Burgos, A.; Ellames, G.J.; Convenient synthesis of [2-C-14]-methylglyoxal bis(guanylhydrazone), [C-14]-mitoguazone. J Label Compd Radiopharm 1995, 36, 1, 93.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
44564 |
potassium acetate
|
127-08-2 |
C2H3KO2 |
详情 | 详情
|
(I) |
44565 |
potassium acetate
|
|
C2H3KO2 |
详情 |
详情
|
(II) |
44566 |
methyl acetate
|
79-20-9 |
C3H6O2 |
详情 | 详情
|
(II) |
44567 |
methyl acetate
|
|
C3H6O2 |
详情 |
详情
|
(III) |
44569 |
[(methoxysulfanyl)methyl]sodium
|
|
C2H5NaOS |
详情 |
详情
|
(IV) |
10014 |
1-Hydroxy-1-(methylsulfanyl)acetone
|
74178-33-9 |
C4H8O2S |
详情 | 详情
|
(IV) |
44568 |
1-Hydroxy-1-(methylsulfanyl)acetone
|
|
C4H8O2S |
详情 |
详情
|
(V) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) The oxidation of acetone (I) with butyl nitrite (II) with a catalytic amount of HCl gives methylglyoxal 1-oxime (III), which is then condensed with aminoguanidine (IV) in hot water acidified with HCl.
【1】
Nagaki, D.; Nishimura, T.; Hasegawa, K.; Toku, H.; Sakaguchi, H.; Yamazaki, C.; Antiviral compounds. IX. Synthesis and anti-influenza virus activity of bis-amidinohydrazones of glyoxal and methylglyoxal. Kitasato Arch Exp Med 1975, 48, 4, 171-181.
|
【2】
Serradell, M.N.; Eastland, G.W.; Castaner, J.; Mitoguazone. Drugs Fut 1984, 9, 3, 199.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(II) |
31340 |
butyl nitrite
|
544-16-1 |
C4H9NO2 |
详情 | 详情
|
(III) |
30362 |
2-oxopropanal oxime
|
306-44-5 |
C3H5NO2 |
详情 | 详情
|
(IV) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) By condensation of 2,6-dichlorobenzaldehyde (I) and aminoguanidine carbonate (II).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27507 |
2,6-dichlorobenzaldehyde
|
83-38-5 |
C7H4Cl2O |
详情 | 详情
|
(II) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) The Grignard condensation of 2,3-dichloroiodobenzene (I) with CO2 by means of Mg / ether gives 2,3-dichlorobenzoic acid (II), which is converted to the corresponding acyl chloride (III) by refluxing with SOCl2.The reaction of (III) with cuprous cyanide and KI in refluxing xylene yields 2,3-dichlorobenzoyl cyanide (IV). Finally, this compound is cyclized with aminoguanidine (V) in DMSO.
【1】
Baxter, M.G.; Elphick, A.R.; Miller, A.A.; Sawyer, D.A. (Glaxo Wellcome plc); 1,2,4-Triazine derivs., process for preparing such cpds., pharmaceutical compsns. and intermediates utilized for this process. CA 1133938; EP 0021121 .
|
【2】
Castaner, J.; Prous, J.; Lamotrigine. Drugs Fut 1986, 11, 6, 456.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24006 |
1,2-dichloro-3-iodobenzene
|
2401-21-0 |
C6H3Cl2I |
详情 | 详情
|
(II) |
24007 |
2,3-dichlorobenzoic acid
|
50-45-3 |
C7H4Cl2O2 |
详情 | 详情
|
(III) |
24008 |
2,3-dichlorobenzoyl chloride
|
2905-60-4 |
C7H3Cl3O |
详情 | 详情
|
(IV) |
24009 |
2-(2,3-dichlorophenyl)-2-oxoacetonitrile; 2,3-Dichlorobenzoylcyanide
|
77668-42-9 |
C8H3Cl2NO |
详情 | 详情
|
(V) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) Condensation of 2,3-dichlorobenzoyl cyanide (I) with aminoguanidine (II) by means of PPA in hot acetonitrile yields 2,3-dichlorobenzoyl cyanide amidinohydrazone (III), which is cyclized to the target 1,2,4-triazine by heating in refluxing propanol with or without DMSO.
【1】
Nadaka, V.; Lexner, J.; Kaspi, J. (Chemagis Ltd.); Process for preparing substd. benzoyl cyanide amidinohydrazones. EP 1127873 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24009 |
2-(2,3-dichlorophenyl)-2-oxoacetonitrile; 2,3-Dichlorobenzoylcyanide
|
77668-42-9 |
C8H3Cl2NO |
详情 | 详情
|
(II) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(III) |
52654 |
2-[cyano(phenyl)methylidene]-1-hydrazinecarboximidamide
|
|
C9H9N5 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(VII) Hydrogenation of 2,3-dichloronitrobenzene (I) with H2 over Ra-Ni in methanol gives 2,3-dichloroaniline (II), which is diazotized with NaNO2 and HCl and treated with CuCN to yield 2,3-dichlorobenzonitrile (III). Hydrolysis of the nitrile (III) with NaOH in refluxing methanol/water affords 2,3-dichlorobenzoic acid (IV), which is treated with hot SOCl2 to provide the corresponding acyl chloride (V). Reaction of (V) with CuCN and KI in refluxing chlorobenzene gives 2,3-dichlorobenzoyl cyanide (VI), which is condensed with aminoguanidine (VII) by means of H2SO4/TsOH in hot toluene to yield 2,3-dichlorobenzoyl cyanide amidinohydrazone (VIII). Finally, this compound is cyclized by treatment with NaOMe in refluxing methanol.
【1】
Srivastava, A.R.; Sasikumar, T.M.; Radhakrishnan, T.V. (RPG Life Sciences Ltd); A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine. WO 0149669 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52655 |
2,3-Dichloronitrobenzene; 1,2-Dichloro-3-Nitrobenzene; Nitro-o-dichlorobenzene
|
3209-22-1 |
C6H3Cl2NO2 |
详情 | 详情
|
(II) |
28562 |
2,3-dichlorophenylamine
|
608-27-5 |
C6H5Cl2N |
详情 | 详情
|
(III) |
30204 |
2,3-dichlorobenzonitrile
|
6574-97-6 |
C7H3Cl2N |
详情 | 详情
|
(IV) |
24007 |
2,3-dichlorobenzoic acid
|
50-45-3 |
C7H4Cl2O2 |
详情 | 详情
|
(V) |
24008 |
2,3-dichlorobenzoyl chloride
|
2905-60-4 |
C7H3Cl3O |
详情 | 详情
|
(VI) |
24009 |
2-(2,3-dichlorophenyl)-2-oxoacetonitrile; 2,3-Dichlorobenzoylcyanide
|
77668-42-9 |
C8H3Cl2NO |
详情 | 详情
|
(VII) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(VIII) |
52654 |
2-[cyano(phenyl)methylidene]-1-hydrazinecarboximidamide
|
|
C9H9N5 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) Condensation of aminoguanidine carbonate (I) with formic acid gives 3-aminotriazole (II), which by treatment with concentrated nitric acid in a sodium nitrite solution gives 3-nitrotriazole (III). N-Alkylation of (III) with bromoacetic acid ethyl ester affords 2-(3-nitro-1,2,4-triazol-1-yl)acetic acid ethyl ester (IV). Reaction of (IV) with 2-methoxyethylamine in dioxane yields AK-2123.
【1】
Horning, E.C.; Organic Syntheses, Vol. 3, 1st Ed. University of Missouri 1995, 95.
|
【2】
Sugita, T.; Masuoka, M.; Nishikawa, Y.; Nishimoto, S.; Zhuo, L.; Sasai, K.; Kagiya, T.; Nitrotriazoles bearing sulfur-substituted side chains: Preparation and characterization as hypoxic cell radiosensitizers. Anti-Cancer Drug Des 1992, 7, 277-84. |
【3】
Huan, L.C.; Rong, S.; AK-2123. Drugs Fut 1995, 20, 7, 659.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
|
34675 |
2-methoxyethylamine; 2-methoxy-1-ethanamine
|
109-85-3 |
C3H9NO |
详情 | 详情
|
(I) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(II) |
12475 |
1H-1,2,4-Triazol-3-amine; 1H-1,2,4-Triazol-3-ylamine
|
61-82-5 |
C2H4N4 |
详情 | 详情
|
(III) |
12476 |
3-Nitro-1H-1,2,4-triazole; 3-Nitro-1,2,4-triazole
|
24807-55-4 |
C2H2N4O2 |
详情 | 详情
|
(IV) |
12477 |
ethyl 2-(3-nitro-1H-1,2,4-triazol-1-yl)acetate
|
|
C6H8N4O4 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(VII) Reaction of 4-acetylpyridine (I) with hot dimethylformamide dimethyl acetal (II) gives the enamino ketone (III), which is then condensed with (3-amino-1H-pyrazol-4-yl)(2-pyridyl)methanone (IV) in boiling acetic acid.
Intermediate (IV), (3-amino-1H-pyrazol-4-yl)(2-pyrid-yl)methanone, is obtained by condensation of 3-oxo-3-(2-pyridyl)propionitrile (V) with dimethylformamide dimethyl acetal (II) to provide 2-(dimethylaminomethylene)-3-oxo-3-(2-pyridyl)propionitrile (VI), which is finally coupled with aminoguanidine nitrate (VII) by means of 10N NaOH in refluxing EtOH
【1】
Castaner, J.; Silvestre, J.S.; Chilman-Blair, K.; Ocinaplon. Drugs Fut 2003, 28, 2, 115-120.
|
【2】
Tomcufcik, A.S.; Dusza, J.P. (Wyeth); (3-Amino-1H-pyrazol-4-yl)(aryl)methanones. EP 0129846; JP 1985013764; US 4900836 .
|
【3】
Dusza, J.P.; Tomcufcik, A.S.; Albright, J.D. (Wyeth); Aryl and heteroaryl 7-(aryl and heteroaryl)-pyrazolo[1,5-a]pyrimidin-3-ylmethanones. DE 3422844; EP 0129847; JP 1985019788 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59510 |
4-Acetylpyridine; Methyl 4-pyridyl ketone
|
1122-54-9 |
C7H7NO |
详情 | 详情
|
(II) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(III) |
59511 |
(E)-3-(dimethylamino)-1-(4-pyridinyl)-2-propen-1-one
|
|
C10H12N2O |
详情 |
详情
|
(IV) |
59512 |
(3-amino-1H-pyrazol-4-yl)(2-pyridinyl)methanone
|
|
C9H8N4O |
详情 |
详情
|
(V) |
59513 |
3-oxo-3-(2-pyridinyl)propanenitrile
|
|
C8H6N2O |
详情 |
详情
|
(VI) |
59514 |
(E)-3-(dimethylamino)-2-(2-pyridinylcarbonyl)-2-propenenitrile
|
|
C11H11N3O |
详情 |
详情
|
(VII) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV) The reaction of decanedioyl dichloride (I) with 3,5-diacetylaniline (II) by means of pyridine in dichloromethane gives the corresponding diamide (III), which is condensed with aminoguanidine (IV) in refluxing aqueous ethanol to afford the target tetrakis amidinohydrazone.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53486 |
Sebacic acid chloride; Sebacoyl chloride; Sebacoyl dichloride; Sebacic acid dichloride
|
111-19-3 |
C10H16Cl2O2 |
详情 | 详情
|
(II) |
53487 |
1-(3-acetyl-5-aminophenyl)-1-ethanone
|
n/a |
C10H11NO2 |
详情 | 详情
|
(III) |
53488 |
N1,N10-bis(3,5-diacetylphenyl)decanediamide |
n/a |
C30H36N2O6 |
详情 | 详情
|
(IV) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VIII) Orcinol (I) is first derivatized to (III) by reaction with sulfonyl chloride (II) in a mixture of aqueous NaHCO3 (sat) and Et2O. Monosulfonate (III) undergoes Mitsunobu reaction with monobenzylated diol (IV) in the presence of PPh3 and DEAD in dichloromethane to yield derivative (V), which is then debenzylated by hydrogenolysis over Pd/C in MeOH, or in THF/HCl/dioxane, to afford (VI). Alcohol (VI) is oxidized with SO3·pyr complex in DMSO/dichloromethane in the presence of DIEA to provide aldehyde (VIII), which finally reacts with aminoguanidine nitrate in EtOH in the presence of HCl/dioxane.
【1】
Soll, R.M.; Lu, T.; Tomczuk, B.; et al.; Amidinohydrazones as guanidine bioisosteres: Application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors. Bioorg Med Chem Lett 2000, 10, 1, 1.
|
【2】
Soll, R.M.; Lu, T.; Fedde, C.L.; Tomczuk, B.E.; Illig, C. (3-Dimensional Pharmaceuticals, Inc.); Amidinohydrazones as protease inhibitors. EP 0906091; JP 2000507588; US 5891909; WO 9736580 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27257 |
5-Methyl-1,3-benzenediol; Orcinol
|
505-15-4 |
C7H8O2 |
详情 | 详情
|
(II) |
30817 |
2-chlorobenzenesulfonyl chloride
|
2905-23-9 |
C6H4Cl2O2S |
详情 | 详情
|
(III) |
30818 |
3-hydroxy-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C13H11ClO4S |
详情 |
详情
|
(IV) |
14687 |
3-(benzyloxy)-1-propanol; 3-(Benzyloxy)propanol
|
4799-68-2 |
C10H14O2 |
详情 | 详情
|
(V) |
30819 |
3-[3-(benzyloxy)propoxy]-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C23H23ClO5S |
详情 |
详情
|
(VI) |
30820 |
3-(3-hydroxypropoxy)-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C16H17ClO5S |
详情 |
详情
|
(VII) |
30821 |
3-methyl-5-(3-oxopropoxy)phenyl 2-chlorobenzenesulfonate
|
|
C16H15ClO5S |
详情 |
详情
|
(VIII) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(V) Condensation of 2-acetylthiophene (I) with dimethylformamide dimethylacetal produced enaminone (II), which was subsequently cyclized to the isoxazole (III) upon treatment with hydroxylamine. Further condensation of (III) with dimethylformamide dimethylacetal, with concomitant isoxazole ring opening, gave rise to the enamino nitrile (IV). This was then cyclized with aminoguanidine nitrate (V) under basic conditions to furnish the intermediate aminopyrazole (VI).
【2】
Tomcufcik, A.S.; Dusza, J.P.; Albright, J.D.; Beer, B. (Wyeth); N-Methyl-N-(-[3-[-2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl]phenyl)acetamide and compsns. and methods related thereto. US 6399621 .
|
【1】
Sorbera, L.A.; Castaner, J.; Martin, L.; Indiplon. Drugs Fut 2003, 28, 8, 739.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24490 |
1-(2-Thienyl)-1-ethanone; 2-Acetylthiophene
|
88-15-3 |
C6H6OS |
详情 | 详情
|
(II) |
59943 |
(E)-3-(dimethylamino)-1-(2-thienyl)-2-propen-1-one
|
|
C9H11NOS |
详情 |
详情
|
(III) |
59944 |
5-(2-thienyl)isoxazole
|
|
C7H5NOS |
详情 |
详情
|
(IV) |
59945 |
(E)-3-(dimethylamino)-2-(2-thienylcarbonyl)-2-propenenitrile
|
|
C10H10N2OS |
详情 |
详情
|
(V) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(VI) |
59946 |
(3-amino-1H-pyrazol-4-yl)(2-thienyl)methanone
|
|
C8H7N3OS |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(V) Reaction of 3-(acetamido)acetophenone (VIII) with iodomethane and NaH gives 3-(N-methylacetamido)acetophenone (XXVIII), which is mixed with 3-oxo-3-(2-thienyl)propionitrile (VII) and treated with dimethylformamide dimethylacetal to yield a mixture of the dimethylaminomethylene derivatives (IV) and (X). This mixture, without isolation, is cyclized with aminoguanidine (V) by treatment first with NaOH in ethanol and then with refluxing AcOH.
【1】
Sorbera, L.A.; Castaner, J.; Martin, L.; Indiplon. Drugs Fut 2003, 28, 8, 739.
|
【2】
Wilcoxen, K.M.; Gross, R.S. (Neurocrine Biosciences Inc.); Synthesis of substd. pyrazolopyrimidines. WO 0110868 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
59945 |
(E)-3-(dimethylamino)-2-(2-thienylcarbonyl)-2-propenenitrile
|
|
C10H10N2OS |
详情 |
详情
|
(V) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(VII) |
62972 |
3-oxo-3-(2-thienyl)propanenitrile
|
|
C7H5NOS |
详情 |
详情
|
(VIII) |
11983 |
3'-Acetamidoacetophane; m-Acetamidoacetophenone; N-(3-Acetylphenyl)acetamide
|
7463-31-2 |
C10H11NO2 |
详情 | 详情
|
(X) |
59947 |
N-{3-[(E)-3-(dimethylamino)-2-propenoyl]phenyl}-N-methylacetamide
|
|
C14H18N2O2 |
详情 |
详情
|
(XXVIII) |
62971 |
N-(3-acetylphenyl)-N-methylacetamide
|
|
C11H13NO2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(VIII) 2-Chlorobenzenesulfonyl chloride (I) was coupled to orcinol (II) to give sulfonate (III). Subsequent condensation of (III) with 3-benzyloxypropanol (IV) under Mitsunobu conditions afforded ether (V). After hydrogenolytic deprotection of the benzyl group, Swern oxidation of the resulting alcohol (VI) with DMSO and SO3-pyridine complex provided aldehyde (VII). The title amidinohydrazone was then obtained by treatment of (VII) with aminoguanidine nitrate (VIII).
【1】
Soll, R.M.; Lu, T.; Fedde, C.L.; Tomczuk, B.E.; Illig, C. (3-Dimensional Pharmaceuticals, Inc.); Amidinohydrazones as protease inhibitors. EP 0906091; JP 2000507588; US 5891909; WO 9736580 .
|
【2】
Tomczuk, B.E.; Stagnaro, T.P.; Fedde, C.L.; Lu, T.; Markotan, T.P.; Illig, C.R.; Soll, R.M. (3-Dimensional Pharmaceuticals, Inc.); Aminoguanidines and alkoxyguanidines as protease inhibitors. EP 0944590; WO 9823565 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30817 |
2-chlorobenzenesulfonyl chloride
|
2905-23-9 |
C6H4Cl2O2S |
详情 | 详情
|
(II) |
27257 |
5-Methyl-1,3-benzenediol; Orcinol
|
505-15-4 |
C7H8O2 |
详情 | 详情
|
(III) |
30818 |
3-hydroxy-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C13H11ClO4S |
详情 |
详情
|
(IV) |
14687 |
3-(benzyloxy)-1-propanol; 3-(Benzyloxy)propanol
|
4799-68-2 |
C10H14O2 |
详情 | 详情
|
(V) |
30819 |
3-[3-(benzyloxy)propoxy]-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C23H23ClO5S |
详情 |
详情
|
(VI) |
30820 |
3-(3-hydroxypropoxy)-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C16H17ClO5S |
详情 |
详情
|
(VII) |
30821 |
3-methyl-5-(3-oxopropoxy)phenyl 2-chlorobenzenesulfonate
|
|
C16H15ClO5S |
详情 |
详情
|
(VIII) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) The condensation of nitroenamine (I) with aminoguanidine (II) afforded compound (III), which was subsequently cyclized to the title pyrazole by treatment with NaOH.
【1】
Makarov, V.; et al.; 4-Nitropyrazole derivatives as new exogenic donors of nitric oxide. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PA-120.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46029 |
(E)-3-amino-3-(dimethylamino)-2-nitro-2-propenenitrile
|
|
C5H8N4O2 |
详情 |
详情
|
(II) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
(III) |
46030 |
2-[(E)-1-amino-2-cyano-2-nitroethenyl]-1-hydrazinecarboximidamide
|
|
C4H7N7O2 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(V) Amination of cyclohexanedione derivative (I) with ammonium acetate in refluxing ethanol affords compound (II), which is converted into tetrahydroquinolinone derivative (IV) by condensation with 3-oxobutylaldehyde dimethylacetal (III) and cyclization by means of KOH in refluxing EtOH. The desired compound is finally obtained by first reaction of ketone (IV) with aminoguanidine hydrochloride (V) in refluxing EtOH/HCl, followed by formation of the corresponding dimethanesulfonate salt by treatment with methanesulfonic acid.
【1】
Fukumoto, S.; et al.; Novel, non-acylguanidine-type Na+/H+ exchanger inhibitors: Synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives. J Med Chem 2002, 45, 14, 3009.
|
【3】
Shiraishi, M.; Fukumoto, S.; Kusumoto, K. (Takeda Chemical Industries, Ltd.); Aminoguanidine hydrazone derivs., process for producing the same and drugs thereof. EP 1057812; JP 2000191641; WO 9942442 .
|
【2】
Imamiya, E.; Fujiwara, S.; Watanabe, T.; Shiraishi, M.; Fukumoto, S.; Kusumoto, K.; Novel, non-acylguanidine type Na+/H+ exchanger inhibitors: Synthesis and biological evaluation of tetrahydroquinolinylidene aminoguanidine derivatives. 20th Symp Med Chem (Dec 6 2000, Tokyo) 2000, Abst 2P-02. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48879 |
5-(5-fluoro-2-methylphenyl)-1,3-cyclohexanedione
|
|
C13H13FO2 |
详情 |
详情
|
(II) |
48880 |
3-amino-5-(5-fluoro-2-methylphenyl)-2-cyclohexen-1-one
|
|
C13H14FNO |
详情 |
详情
|
(III) |
48881 |
Acetoacetaldehyde Dimethylacetal; 1,1-dimethoxy-3-butanone; 3-Ketobutyraldehyde dimethyl acetal; 3-Ketobutyric aAldehyde 1-dimethylacetal; 3-Oxobutyraldehyde dimethylacetal; 4,4-Dimethoxy-2-butanone
|
5436-21-5 |
C6H12O3 |
详情 | 详情
|
(IV) |
48882 |
7-(5-fluoro-2-methylphenyl)-4-methyl-7,8-dihydro-5(6H)-quinolinone
|
|
C17H16FNO |
详情 |
详情
|
(V) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) The title compound is prepared by condensation of 2-chloro-3,4-dimethoxybenzaldehyde (I) with aminoguanidine bicarbonate (II) in the presence of HOAc in refluxing MeOH.
【1】
Skottner, A.; Lundstedt, T.; Seifert, E.; Veveris, M.; Piskunova, I.; Rozhkov, E.; Wikberg, J.; Pett, C.P.; Kalvins, I.; Andrianov, V.; Semenikhina, V.; Dambrova, M. (Melacure Therapeutics); Guanidine derivs. and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase. WO 0125192 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
57570 |
2-chloro-3,4-dimethoxybenzaldehyde
|
|
C9H9ClO3 |
详情 |
详情
|
(II) |
10015 |
1-Hydrazinecarboximidamide; Hydrazinecarboximidamide
|
79-17-4 |
CH6N4 |
详情 | 详情
|